September 05, 2024

Obesity Increases SARS-CoV-2 Infection Risk

Study reveals patients with obesity exposed to SARS-CoV-2 had higher odds of testing positive, suggesting obesity as an intrinsic risk factor for COVID-19 transmission and potentially influencing resource allocation strategies.

Conexiant

August 30, 2024

Tonsillectomy: No Weighty Concerns for Kids

One-third of children gained undesirable weight during the study, regardless of adenotonsillectomy, highlighting an opportunity for weight management discussions in pediatric oSDB care.

Conexiant

August 28, 2024

SVT in Children with Asthma: Higher Mortality Risk

Asthmatic children with SVT faced a 4.3-fold higher risk of death or cardiac arrest than those without SVT, a large-scale study of over 91,000 patients revealed.

Conexiant

August 26, 2024

Ibuprofen and Childhood Asthma Risk Examined

A systematic review of 24 studies found no significant difference in asthma risk between ibuprofen and acetaminophen use in children, but short-term ibuprofen use may exacerbate asthma symptoms in those with pre-existing asthma.

Conexiant

August 23, 2024

Pediatric Long COVID Symptoms: Age Matters

Long COVID symptoms differ between children and teens, with 20% of infected school-age children and 14% of adolescents meeting PASC criteria in a large-scale study.

Conexiant

August 19, 2024

Methyl Mercury Exposure May Increase Risk of Latent TB Infection

A recent study links higher methyl mercury levels to increased risk of latent tuberculosis infection. MeHg may have public health implications for TB infection risk. (Source: BMC Pulmonary Medicine)

Conexiant

August 15, 2024

Genetic Risk Linked to Early Lung Function Decline in COPD

Is a polygenic risk score for COPD associated with lower lung function in childhood and up to adulthood?

Conexiant

August 12, 2024

Study: U.S. Child Allergy Rates Shifted During Pandemic

A recent study examined the prevalence of allergies and asthma among U.S. children and adolescents before and during the COVID-19 pandemic, revealing interesting trends and potential associations with lifestyle changes due to the pandemic.

Conexiant

August 12, 2024

RSV Vaccine Effective in Immunocompromised Adults: Study

A recent study reveals the effectiveness of the Abrysvo vaccine in generating a strong immune response against respiratory syncytial virus (RSV) in immunocompromised adults, potentially offering significant protection for high-risk groups.

Reuters